Piper Jaffray Upgrades Array BioPharma (ARRY) to Overweight

March 25, 2013 6:41 AM EDT Send to a Friend
Get Alerts ARRY Hot Sheet
Price: $3.95 +0.77%

Rating Summary:
    4 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 12 | New: 23
Trade ARRY Now!
Join SI Premium – FREE
Piper Jaffray upgraded Array BioPharma (NASDAQ: ARRY) from Neutral to Overweight.

For an analyst ratings summary and ratings history on Array BioPharma click here. For more ratings news on Array BioPharma click here.

Shares of Array BioPharma closed at $4.29 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Related Entities

Piper Jaffray

Add Your Comment